Microbot Medical
Update in progressMBOT (NasdaqCM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Microbot Medical is a medical device company focused on robotic endoluminal surgery for minimally invasive procedures. It develops LIBERTY, an endovascular robotic system that maneuvers guidewires and over-the-wire devices within blood vessels for cardiovascular, peripheral, endovascular, and neurovascular procedures. It also offers NovaCross, an intraluminal revascularization technology with an anchoring mechanism and integrated microcatheter. Founded in 2010, it is based in Hingham, Massachusetts, with collaborations including Corewell Health and Emory University.
Company score
- Sentiment
- 0.55
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.18
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.58
- Governance
- 0.16
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.27
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.41
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqCM (NCM)
- LocationUnited States
- CEOMr. Harel Gadot
- Founded2010
- Employees43
- Websitemicrobotmedical.com
Identifiers
- ISINUS59503A2042
- FIGIBBG000HPJ656
- LEI549300AEUNO16KTJXD72
- CUSIP232923102
- CIK0000883975